AZN - Spark Newswire

3 minute read

AstraZeneca Announced Enhertu Approved in the EU for Patients With HER2-Positive Metastatic Breast Cancer Treated With One or More Prior Anti-HER2-based Regimens

Today, 8:59 AM

Approval broadens indication for AstraZeneca and Daiichi Sankyo's Enhertu across Europe to earlier use in HER2-positive metastatic breast cancer. Based on ground-breaking DESTINY-Breast03 results in which Enhertu demonstrated a 72% reduction in the risk of disease progression or death vs. trastuzumab emtansine (T-DM1).

AZN

1 minute read

WHO, UNICEF Sound Alarm As Pandemic Leads Largest Fall In Kids Vaccinations In 30 Years

By Vandana Singh

Today, 8:59 AM

According to the United Nations Children’s Fund (UNICEF) and the World Health Organization (WHO), approximately 25 million children worldwide missed routine…

AZN

1 minute read

FDA
News

AstraZeneca Says Vaxzevria 73% Effective At Preventing Omicron-related Infections After Fourth Dose, According To Real World Evidence Study In Thailand

By Benzinga Newsdesk

Today, 8:59 AM

-Reuters

AZN

1 minute read

If You Invested $100 In This Stock 5 Years Ago, You Would Have $200 Today

By Benzinga Insights

Today, 8:59 AM

AstraZeneca (NASDAQ:AZN) has outperformed the market over the past 5 years by 5.58% on an annualized basis producing an average annual return of 14.99%. Currently, AstraZeneca has a market capitalization of $208.75 billion.

AZN

1 minute read

HUTCHMED Highlights SAVANNAH Trial Data Of Savolitinib Combo In Lung Cancer Setting

By Vandana Singh

Today, 8:59 AM

HUTCHMED (China) Limited (NASDAQ:HCM) announced the first presentation of results from the ongoing SAVANNAH Phase 2 trial at the upcoming World…

AZN

3 minute read

The Daily Biotech Pulse: AstraZeneca’s COVID-19 Vaccine As Effective As mRNA Shots, Humanigen’s Lenzilumab Disappoints In COVID-19 Study, Positive Preclinical Data From Hoth’s Alzheimer’s Program

By Vandana Singh

Today, 8:59 AM

Here's a roundup of top developments in the biotech space over the last 24 hours:

AGIO

5 minute read

Benzinga Before The Bell: Most Effective Covid-19 Vaccine, Google’s Hiring Slowdown, Panasonic’s New EV Battery And Other Top Financial Stories Wednesday, July 13

By Akanksha Bakshi

Today, 8:59 AM

CNBC Bankrupt Crypto Firm Three Arrows Capital’s Assets Frozen By New York Judge

AZN

2 minute read

News

AstraZeneca Announced Vaxzevria Shown in Expert Review to Provide Equally Effective Protection Against COVID-19 hospitalization and Death as mRNA Vaccines

By Charles Gross

Today, 8:59 AM

An expert review of data from 79 real-world studies showed that AstraZeneca's COVID-19 vaccine, Vaxzevria (ChAdOx1-S [Recombinant]) and the available mRNA COVID-19 vaccines provide equally effective protection against hospitalisation and death from COVID-19 following two doses.1

AZN

1 minute read